Mckesson Ultracell Eye Pledgets Recalled Over Temperature Exposure During Storage
Mckesson Medical-Surgical is recalling Ultracell Eye Pledgets (Model 40825) due to temperature excursions during storage and transportation between June and August 2021 that may have compromised product effectiveness. Affected units were distributed nationwide from June through September 2021.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a sterile medical device where temperature excursions during storage may have compromised product effectiveness. It meets the criterion for a risk-of-harm product where injury has not yet been reported. Although classified as FDA Class II, no hospitalization or injury reports are documented, placing it below the Severe threshold but above Moderate due to the inherent risk associated with compromised sterile surgical devices.
Plain-English summary
Mckesson Medical-Surgical Inc. is recalling Ultracell Eye Pledgets (Model 40825), sterile surgical medical devices used in ophthalmic procedures. The recall affects all units distributed in the United States between June 1, 2021, and September 30, 2021.
The recalled products were stored in facilities where temperature excursions occurred between June and August 2021, prior to delivery. Exposure to temperatures higher than intended may have impacted the product's effectiveness and ability to perform as designed during surgical use.
No illnesses or injuries related to this recall have been reported. Patients who have received this device or healthcare providers with inventory of affected lots should contact Mckesson Medical-Surgical Inc. for instructions on obtaining replacements or for additional information.
The recalled product
- Product
- Ultracell Eye Pledget Ultracell 2 X 6 X 1 mm, Sterile Model Number: 40825
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- GTIN: 00886158012108
- 30886158012109
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 55 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 55 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
Similar recalls
- HighProparacaine Hydrochloride Eye Drops Recalled Due to Temperature Exposure
FDA (Drugs) · 2024-10-02
- ModerateSaline wound flush recalled due to temperature exposure affecting effectiveness
FDA (Devices) · 2022-10-05
- ModerateMcKesson Calcium Alginate Wound Dressings Recalled for Temperature Exposure During Storage
FDA (Devices) · 2022-10-05
- ModerateMcKesson Wound Dressing Products Recalled for Temperature Exposure
FDA (Devices) · 2022-10-05
- ModerateMedical Monofilament Testing Devices Recalled for Temperature Excursion
FDA (Devices) · 2022-10-05
- ModerateWound Dressing Units Recalled Due to Storage Temperature Excursions
FDA (Devices) · 2022-10-05